|
LTA4H expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.75430000315791E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25099930414763E-11 |
| Normal-vs-Stage2 |
6.246100E-02 |
| Normal-vs-Stage3 |
1.347850E-02 |
| Normal-vs-Stage4 |
1.798760E-01 |
| Stage1-vs-Stage2 |
3.630100E-02 |
| Stage1-vs-Stage3 |
1.340390E-03 |
| Stage1-vs-Stage4 |
2.384800E-04 |
| Stage2-vs-Stage3 |
8.266600E-01 |
| Stage2-vs-Stage4 |
4.291400E-01 |
| Stage3-vs-Stage4 |
4.484800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.53640000008804E-08 |
| Normal-vs-AfricanAmerican |
6.072000E-02 |
| Normal-vs-Asian |
3.077000E-01 |
| Caucasian-vs-AfricanAmerican |
1.897600E-01 |
| Caucasian-vs-Asian |
5.218800E-01 |
| AfricanAmerican-vs-Asian |
8.934800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.54009999992533E-07 |
| Normal-vs-Female |
1.65379999994553E-06 |
| Male-vs-Female |
7.253600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.756300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.71001000000004E-05 |
| Normal-vs-Age(61-80Yrs) |
8.56559999595774E-08 |
| Normal-vs-Age(81-100Yrs) |
5.527800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.270800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.100200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.990200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.403400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.297800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.149780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.09149999999647E-06 |
| Normal-vs-Grade 2 |
1.11577413974828E-13 |
| Normal-vs-Grade 3 |
3.783100E-04 |
| Normal-vs-Grade 4 |
2.936400E-01 |
| Grade 1-vs-Grade 2 |
7.366400E-01 |
| Grade 1-vs-Grade 3 |
7.047900E-02 |
| Grade 1-vs-Grade 4 |
7.432500E-04 |
| Grade 2-vs-Grade 3 |
4.45510000000038E-05 |
| Grade 2-vs-Grade 4 |
1.13269948975869E-10 |
| Grade 3-vs-Grade 4 |
3.026600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.250800E-01 |
| ccA subtype-vs-ccB subtype |
2.87103674168065E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58720000043422E-07 |
| Normal-vs-N1 |
7.679000E-01 |
| N0-vs-N1 |
1.333190E-01 |
|
|
